AGTR1 and hypertensive disorder: Azilsartan is a drug approved worldwide for the treatment of hypertension, either as a prodrug (azilsartan medoxomil) or a primary compound (Pradhan et al., 2019[93]) and has more affinity to the AT1R than to the AT2 receptor.